SEC Form 4 · accession 0001140361-15-039943
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Kramer
Officer — EVP, Corporate Services Div
Period of report
Nov 4, 2015
Accepted (ET)
Nov 6, 2015 · 11:49 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 4, 2015 | F | 1,234 | $33.53 | D | 69,879 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock incentive Plan, as amended.